Literature DB >> 8554032

Stevens-Johnson syndrome resulting from whole-brain radiation and phenytoin.

G H Cockey1, S T Amann, S B Reents, J W Lynch.   

Abstract

Phenytoin, one of the most widely prescribed anticonvulsants, and steroids are routinely utilized for seizure prophylaxis in patients with various intracranial tumors. We report a case of severe Stevens-Johnson syndrome (SJS), documented by biopsy, which occurred in a patient, with metastatic squamous cell carcinoma receiving phenytoin, whole-brain radiation therapy (WBRT), and a tapering steroid dose. The pathogenesis and implications are then briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8554032     DOI: 10.1097/00000421-199602000-00007

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  5 in total

Review 1.  Brain metastases: treatment options to improve outcomes.

Authors:  Phillip Davey
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  Multifocal Stevens-Johnson syndrome after concurrent phenytoin and cranial and thoracic radiation treatment, a case report.

Authors:  Abdullah O Kandil; Tomas Dvorak; John Mignano; Julian K Wu; Jay-Jiguang Zhu
Journal:  Radiat Oncol       Date:  2010-06-04       Impact factor: 3.481

3.  Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider.

Authors:  David Aguiar; Roberto Pazo; Ignacio Durán; Josefa Terrasa; Antonio Arrivi; Herminio Manzano; Javier Martín; Julio Rifá
Journal:  J Neurooncol       Date:  2004-02       Impact factor: 4.130

4.  Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020.

Authors:  Liqin Wang; Sheril Varghese; Fatima Bassir; Ying-Chin Lo; Carlos A Ortega; Sonam Shah; Kimberly G Blumenthal; Elizabeth J Phillips; Li Zhou
Journal:  Front Med (Lausanne)       Date:  2022-08-24

Review 5.  Use of prophylactic anticonvulsants in neurologic critical care: a critical appraisal.

Authors:  Kenneth C Liu; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.532

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.